Publications by authors named "Eliza A Hawkes"

45Publications

Caution in Expanding the Use of Abbreviated R-CHOP to Poor-Risk Limited-Stage DLBCL.

J Clin Oncol 2020 Oct 26:JCO2002301. Epub 2020 Oct 26.

Eliza A. Hawkes, MBBS, DMedSc, Department of Clinical Haematology and Medical Oncology, Olivia Newton-John Cancer Research Institute at Austin Health, Heidelberg, Victoria, Australia; Stephen Opat, MBBS, Clinical Haematology, School of Clinical Sciences at Monash Health, Monash University, Clayton, Victoria, Australia; and Mark Hertzberg, MBBS, PhD, Department of Haematology, Prince of Wales Hospital and University of New South Wales, Randwick, New South Wales, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.20.02301DOI Listing
October 2020

Routine Blood Tests in Asymptomatic Patients With Indolent Lymphoma Have Limited Ability to Detect Clinically Significant Disease Progression.

JCO Oncol Pract 2020 Nov 25;16(11):e1315-e1323. Epub 2020 Jun 25.

Department of Oncology and Clinical Haematology, Olivia Newton John Cancer Research and Wellness Centre, Austin Hospital, Melbourne, Victoria, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JOP.19.00771DOI Listing
November 2020

A consensus statement on the use of biosimilar medicines in hematology in Australia.

Asia Pac J Clin Oncol 2020 Aug 14;16(4):211-221. Epub 2020 Apr 14.

Monash Haematology, Monash Health, Clayton, Victoria, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/ajco.13337DOI Listing
August 2020

Patient selection and tolerability of high-dose methotrexate as central nervous system prophylaxis in diffuse large B-cell lymphoma.

Cancer Chemother Pharmacol 2020 01 17;85(1):133-140. Epub 2019 Dec 17.

The University of Melbourne, Parkville, VIC, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00280-019-04007-wDOI Listing
January 2020

Comprehensive geriatric assessment is useful in an elderly Australian population with diffuse large B-cell lymphoma receiving rituximab-chemotherapy combinations.

Br J Haematol 2019 10 17;187(1):73-81. Epub 2019 Jun 17.

Department of Haematology and Medical Oncology, Olivia Newton-John Cancer Research and Wellness Centre, Austin Health, Melbourne, Australia.

View Article

Download full-text PDF

Source
https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.16049
Publisher Site
http://dx.doi.org/10.1111/bjh.16049DOI Listing
October 2019

Dose-adjusted EPOCH-R therapy in MYC-rearranged diffuse large B-cell lymphoma: not yet the standard of care.

Lancet Haematol 2019 03;6(3):e119

The Olivia Newton-John Cancer Research Institute, Heidelberg, VIC 3084, Australia. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/S2352-3026(19)30013-4DOI Listing
March 2019

Urine cultures at the onset of febrile neutropenia rarely impact antibiotic management in asymptomatic adult cancer patients.

Support Care Cancer 2019 Apr 27;27(4):1223-1227. Epub 2018 Sep 27.

University of Melbourne, Parkville, Victoria, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00520-018-4476-7DOI Listing
April 2019

Routine blood investigations have limited utility in surveillance of aggressive lymphoma in asymptomatic patients in complete remission.

Br J Cancer 2018 08 23;119(5):546-550. Epub 2018 Jul 23.

Department of Oncology and Clinical Haematology, Austin Hospital, Heidelberg, VIC, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/s41416-018-0183-xDOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6162229PMC
August 2018

Prognostication of diffuse large B-cell lymphoma in the molecular era: moving beyond the IPI.

Blood Rev 2018 09 26;32(5):400-415. Epub 2018 Mar 26.

Olivia Newton John Cancer Research and Wellness Centre, Austin Health, Heidelberg, Australia; University of Melbourne, Melbourne, Australia; Eastern Health, Box Hill, Australia. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.blre.2018.03.005DOI Listing
September 2018

An abscopal effect may augment PD-1 inhibition in refractory classical Hodgkin lymphoma.

Leuk Lymphoma 2018 11 23;59(11):2749-2751. Epub 2018 Mar 23.

a Department of Haematology , Olivia Newton John Cancer and Wellness Centre, Austin Health , Heidelberg , Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1080/10428194.2018.1452217DOI Listing
November 2018

Echocardiography has low utility in cancer patients with Staphylococcus aureus bacteraemia: findings from a retrospective study.

Support Care Cancer 2018 Sep 21;26(9):3083-3089. Epub 2018 Mar 21.

Department of Medical Oncology & Clinical Haematology, Olivia Newton John Cancer Research and Wellness Centre, Austin Health, Heidelberg, Victoria, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00520-018-4162-9DOI Listing
September 2018

Novel Indications for Bruton's Tyrosine Kinase Inhibitors, beyond Hematological Malignancies.

J Clin Med 2018 Mar 21;7(4). Epub 2018 Mar 21.

Department of Medical Oncology and Clinical Haematology, Olivia Newton-John Cancer Research Institute, Austin Health, Heidelberg, VIC 3084, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3390/jcm7040062DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5920436PMC
March 2018

Limited utility of routine chest X-ray in initial evaluation of neutropenic fever in patients with haematological diseases undergoing chemotherapy.

Intern Med J 2018 05;48(5):556-560

Department of Clinical Haematology and Medical Oncology, Olivia Newton John Cancer Research and Wellness Centre, Austin Health, Melbourne, Victoria, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/imj.13712DOI Listing
May 2018

Chemoimmunotherapy May Not Be Dead Yet in Chronic Lymphocytic Leukemia, But Fludarabine Plus Cyclophosphamide Plus Rituximab Is Potentially Facing Life Support.

J Clin Oncol 2017 12 3;35(36):4093-4094. Epub 2017 Nov 3.

Stephen Opat, Monash Health, Clayton, Australia; Monash University, Melbourne, Australia; and Eliza A. Hawkes, Monash University, Melbourne, Australia; Austin Health, Heidelberg, Australia; Eastern Health, Box Hill, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2017.75.4721DOI Listing
December 2017

Is Upfront Escalated BEACOPP for Advanced Hodgkin Lymphoma Becoming a Distant Memory?

J Clin Oncol 2017 01 28;35(3):371-372. Epub 2016 Oct 28.

Eliza A. Hawkes, Olivia Newton-John Cancer Wellness & Research Centre, Austin Hospital; and Eastern Health, Melbourne, Victoria, Australia; and Geoffrey Chong and Andrew Grigg, Olivia Newton-John Cancer Wellness & Research Centre, Austin Hospital, Melbourne, Victoria, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2016.68.2047DOI Listing
January 2017

Efficacy and toxicity of PACEBOM chemotherapy in relapsed/refractory aggressive lymphoma in the rituximab era.

Asia Pac J Clin Oncol 2017 Jun 22;13(3):226-233. Epub 2016 Dec 22.

Oncology and Haematology Department, Box Hill Hospital, Melbourne, Victoria, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/ajco.12611DOI Listing
June 2017

Tumour cell surface antigen targeted therapies in B-cell lymphomas: Beyond rituximab.

Blood Rev 2017 01 12;31(1):23-35. Epub 2016 Aug 12.

Department of Clinical Haematology and Oncology, Olivia Newton John Cancer Research Institute, Austin Hospital, Heidelberg, Australia; Eastern Health, Melbourne, Australia. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.blre.2016.08.001DOI Listing
January 2017

Hodgkin lymphoma: an Australian experience of ABVD chemotherapy in the modern era.

Ann Hematol 2016 Apr 15;95(5):809-16. Epub 2016 Feb 15.

Eastern Health, Monash University Clinical School, Melbourne, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00277-016-2611-4DOI Listing
April 2016

Caution in the Use of Immunohistochemistry for Determination of Cell of Origin in Diffuse Large B-Cell Lymphoma.

J Clin Oncol 2015 Oct 10;33(28):3215-6. Epub 2015 Aug 10.

University College London, London, United Kingdom.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2014.60.6731DOI Listing
October 2015

Treatment of metastatic colorectal cancer: focus on panitumumab.

Cancer Manag Res 2015 24;7:189-98. Epub 2015 Jun 24.

Department of Medical Oncology, Eastern Health, Box Hill, VIC, Australia ; Faculty of Medicine, Nursing and Health Sciences, Monash University, Melbourne, VIC, Australia ; Department of Oncology, Olivia Newton John Cancer and Wellness Centre, Austin Hospital, Heidelberg, VIC, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2147/CMAR.S71821DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4484697PMC
July 2015

Programmed cell death-1 inhibition in lymphoma.

Lancet Oncol 2015 May;16(5):e234-45

Department of Medical Oncology and Clinical Haematology, Olivia Newton John Cancer and Wellness Centre, Austin Hospital, Melbourne, VIC, Australia; Department of Oncology, Northern Hospital, Melbourne, VIC, Australia; Department of Medical Oncology, Ballarat Health Services, Ballarat, VIC, Australia.

View Article

Download full-text PDF

Source
https://linkinghub.elsevier.com/retrieve/pii/S14702045157010
Publisher Site
http://dx.doi.org/10.1016/S1470-2045(15)70103-8DOI Listing
May 2015

Diagnostic medical radiation exposure in surveillance of aggressive lymphoma: clinical trial design should reflect clinical practice.

J Clin Oncol 2015 Apr 17;33(10):1219-20. Epub 2015 Feb 17.

ONJ Cancer Research Institute, Austin Hospital and Eastern Health, Melbourne, Victoria, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2014.60.0486DOI Listing
April 2015

ASPECCT: panitumumab versus cetuximab for colorectal cancer.

Lancet Oncol 2014 Jul;15(8):e302-3

Department of Medical Oncology, Eastern Health, Box Hill, VIC, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/S1470-2045(14)70269-4DOI Listing
July 2014

GEM-P chemotherapy is active in the treatment of relapsed Hodgkin lymphoma.

Ann Hematol 2014 May 26;93(5):827-34. Epub 2013 Oct 26.

Royal Marsden NHS Foundation Trust, Downs Rd Sutton, Surrey, SM2 5PT, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00277-013-1930-yDOI Listing
May 2014

Rare case of precursor B-cell acute lymphoblastic leukemia presenting as a solitary paraspinal mass alone.

J Clin Oncol 2013 Aug 24;31(22):e383-5. Epub 2013 Jun 24.

Flinders Centre for Innovation in Cancer, Flinders Medical Centre, Flinders University, Bedford Park, SA, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2012.47.2308DOI Listing
August 2013

Are we ready to stratify treatment for diffuse large B-cell lymphoma using molecular hallmarks?

Oncologist 2012 18;17(12):1562-73. Epub 2012 Oct 18.

Department of Medicine, Royal Marsden Hospital, Downs Road, Sutton, Surrey, SM2 5PT, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1634/theoncologist.2012-0218DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3528389PMC
June 2013

Diagnosis and management of rare gastrointestinal lymphomas.

Leuk Lymphoma 2012 Dec 21;53(12):2341-50. Epub 2012 Jun 21.

Royal Marsden Hospital, London and Surrey, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3109/10428194.2012.695780DOI Listing
December 2012

Reply to M. Mohiuddin et al.

J Clin Oncol 2011 Jul;29(19):2737-8

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2011.36.2186DOI Listing
July 2011

The unique entity of nodular lymphocyte-predominant Hodgkin lymphoma: current approaches to diagnosis and management.

Leuk Lymphoma 2012 Mar 19;53(3):354-61. Epub 2011 Sep 19.

Royal Marsden Hospital, London & Surrey, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3109/10428194.2011.608455DOI Listing
March 2012

Integration of biologic agents with cytotoxic chemotherapy in metastatic colorectal cancer.

Clin Colorectal Cancer 2011 Dec 10;10(4):245-57. Epub 2011 May 10.

Royal Marsden Hospital, London, Surrey, United Kingdom.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.clcc.2011.04.001DOI Listing
December 2011

Neoadjuvant chemotherapy alone for early-stage rectal cancer: an evolving paradigm?

Semin Radiat Oncol 2011 Jul;21(3):196-202

Royal Marsden Hospital, London & Surrey, United Kingdom.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.semradonc.2011.02.005DOI Listing
July 2011

Flexible sigmoidoscopy--valuable in colorectal cancer.

Nat Rev Clin Oncol 2010 Sep;7(9):488-90

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/nrclinonc.2010.102DOI Listing
September 2010

Metastatic breast cancer presenting as a primary hindgut neuroendocrine tumour.

Anticancer Res 2010 Jul;30(7):3015-8

Department of Medicine, Royal Marsden Hospital, Downs Road, Sutton, Surrey, SM2 5PT, U.K.

View Article

Download full-text PDF

Source
July 2010